Ocugen to Present at Upcoming November 2026 Investor Conferences
Ocugen announced it will present on its modifier gene therapy platform at upcoming investor and industry conferences in November 2026, including the Stifel 2026 Healthcare Conference.
Stocks · News reference
Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
Ocugen, Inc. announced it will host a conference call and live webcast on November 4, 2026, to discuss its business progress and report financial results for the third quarter of 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Ocugen, Inc. (OCGN)
Filed: 2026-10-15 AccNo: 0001104659-26-115970 Size: 7 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Ocugen shares are trading lower. The company announced a licensing agreement with Roots Pharmaceutical for exclusive MENA rights to OCU400, its gene therapy for Retinitis Pigmentosa.